In the 2014 guidelines, the American Diabetes Association (ADA) recommends determination of ATG or EMA of the IgA class shortly after diagnosis of diabetes and exclusion of IgA deficiency. The gene discussed is CD79A; the disease is selective IgA deficiency disease.